Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
22.02
-0.15 (-0.68%)
At close: May 22, 2026, 4:00 PM EDT
21.80
-0.22 (-1.00%)
After-hours: May 22, 2026, 6:52 PM EDT
Alumis Market Cap
Alumis has a market cap or net worth of $2.81 billion as of May 22, 2026. Its market cap has increased by 869.91% in one year.
Market Cap
2.81B
Enterprise Value
2.27B
1-Year Change
869.91%
Ranking
Category
Stock Price
$22.02
Market Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has increased from $901.92M to $2.81B, an increase of 211.27%. That is a compound annual growth rate of 81.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.81B | 175.54% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 3.05B |
| Denali Therapeutics | 2.99B |
| Arcus Biosciences | 2.99B |
| Dyne Therapeutics | 2.90B |
| Tarsus Pharmaceuticals | 2.79B |
| Beam Therapeutics | 2.70B |
| Structure Therapeutics | 2.62B |
| IDEAYA Biosciences | 2.61B |